Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs iShares Semiconductor ETF (SOXX) Price & Performance

Oruka Therapeutics Inc. Common StockTrade
iShares Semiconductor ETFTrade

Price performance (Past 24H)

Key statistics

Oruka Therapeutics Inc. Common Stock vs iShares Semiconductor ETF — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while iShares Semiconductor ETF trades at $503.48 (market cap $44.53B). The key difference: iShares Semiconductor ETF is far larger — about 8.6× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (490,798 versus 8,354,155). Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and iShares Semiconductor ETF for 47 Days on average.

ORKASOXX
Market Cap
$5.18B$44.53B
Volume
490,7988,354,155
Sector
HealthSector/Thematic
52-Week High
$113.08$655.01
52-Week Low
$26.19$268.10
Typical Hold Time
0 Days47 Days
Enterprise Value
$4.31B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

iShares Semiconductor ETF

SOXX trades at $543.9, down 0.17% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The semiconductor ETF faces mixed sentiment with strong AI-driven earnings growth projections but elevated valuation concerns. Recent news highlights Michael Burry's expanded short position while other analysts point to continued earnings momentum supporting the sector.

The semiconductor sector outlook remains bifurcated between strong AI-driven fundamentals and valuation risks. SOXX's investment case hinges on sustained AI infrastructure demand, though current technical weakness and high multiples relative to broader markets warrant caution. Key risks include sector concentration and potential AI development slowdowns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORKA
100% Buy0% Sell
Avg holding period · 0 Days
SOXX
51% Buy49% Sell
Avg holding period · 47 Days

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →

About iShares Semiconductor ETF

SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.

Read more on SOXX →